Dr. George Priya Doss C
Cited by
Cited by
Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine
C Chakraborty, AR Sharma, G Sharma, CGP Doss, SS Lee
Molecular Therapy-Nucleic Acids 8, 132-143, 2017
Influence of miRNA in insulin signaling pathway and insulin resistance: micro‐molecules with a major role in type‐2 diabetes
C Chakraborty, CGP Doss, S Bandyopadhyay, G Agoramoorthy
Wiley interdisciplinary reviews: RNA 5 (5), 697-712, 2014
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes
G Sharma, AR Sharma, JS Nam, GPC Doss, SS Lee, C Chakraborty
Journal of nanobiotechnology 13 (1), 1-13, 2015
Identification and in silico analysis of functional SNPs of the BRCA1 gene
R Rajasekaran, C Sudandiradoss, CGP Doss, R Sethumadhavan
Genomics 90 (4), 447-452, 2007
Molecular dynamics: new frontier in personalized medicine
P Sneha, CGP Doss
Advances in protein chemistry and structural biology 102, 181-224, 2016
BSA nanoparticle loaded atorvastatin calcium—a new facet for an old drug
AR Sripriyalakshmi. S, Anjali. C. H, George Priya Doss. C, Rajith B
PLOS ONE 9 (e86317), 2014
Screening of mutations affecting protein stability and dynamics of FGFR1—A simulation analysis
CGP Doss, B Rajith, N Garwasis, PR Mathew, AS Raju, K Apoorva, ...
Applied & translational genomics 1, 37-43, 2012
The rise and impact of COVID-19 in India
SU Kumar, DT Kumar, BP Christopher, C Doss
Frontiers in medicine 7, 250, 2020
Investigation on the role of nsSNPs in HNPCC genes–a bioinformatics approach
CGP Doss, R Sethumadhavan
Journal of biomedical science 16 (1), 1-14, 2009
miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the ‘minute and miracle’molecule moving as a monitor in the ‘genomic galaxy’
C Chakraborty, D Priya, S Bandyopadhyay
Current drug targets 14 (10), 1110-1117, 2013
Investigating the structural impacts of I64T and P311S mutations in APE1-DNA complex: a molecular dynamics approach
CGP Doss, N NagaSundaram
PLoS One 7 (2), e31677, 2012
TNF/TNFR: drug target for autoimmune diseases and immune-mediated inflammatory diseases.
GP Doss, G Agoramoorthy, C Chakraborty
Frontiers in bioscience (Landmark edition) 19, 1028-1040, 2014
A novel computational and structural analysis of nsSNPs in CFTR gene
CGP Doss, R Rajasekaran, C Sudandiradoss, K Ramanathan, R Purohit, ...
Genomic medicine 2 (1), 23-32, 2008
DNA barcoding to map the microbial communities: current advances and future directions
C Chakraborty, CGP Doss, BC Patra, S Bandyopadhyay
Applied microbiology and biotechnology 98 (8), 3425-3436, 2014
Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach
CGP Doss, N Nagasundaram, C Chakraborty, L Chen, H Zhu
Human genomics 7 (1), 1-15, 2013
Nanoparticles as' smart'pharmaceutical delivery.
C Chakraborty, S Pal, GP Doss, ZH Wen, CS Lin
Frontiers in bioscience (Landmark edition) 18, 1030-1050, 2013
Applications of computational algorithm tools to identify functional SNPs
CGP Doss, C Sudandiradoss, R Rajasekaran, P Choudhury, P Sinha, ...
Functional & integrative genomics 8 (4), 309-316, 2008
Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation
SK Ali, P Sneha, J Priyadharshini Christy, H Zayed, C George Priya Doss
Journal of Biomolecular Structure and Dynamics 35 (12), 2714-2724, 2017
Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors
B Rajith, C Chakraborty, N NagaSundaram, SK Ali, H Zhu
Scientific reports 4 (1), 1-7, 2014
Integrating in silico prediction methods, molecular docking, and molecular dynamics simulation to predict the impact of ALK missense mutations in structural perspective
CG Priya Doss, C Chakraborty, L Chen, H Zhu
BioMed research international 2014, 2014
The system can't perform the operation now. Try again later.
Articles 1–20